{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:05:56Z","timestamp":1773957956957,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brazilian Ministry of Science, Technology and Innovation","award":["10429"],"award-info":[{"award-number":["10429"]}]},{"name":"Brazilian Ministry of Science, Technology and Innovation","award":["301794\/2022-7"],"award-info":[{"award-number":["301794\/2022-7"]}]},{"name":"Fonds de recherche du Qu\u00e9bec \u2013 Sant\u00e9","award":["330287"],"award-info":[{"award-number":["330287"]}]},{"name":"McGill Global Health Programs","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"World Health Organization Global TB Programme","award":["2023\/1325041"],"award-info":[{"award-number":["2023\/1325041"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,8,15]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>To eliminate tuberculosis (TB) in Brazil, scaling up screening and prevention strategies will be essential. We estimated costs of TB services in Brazil to support budgeting, cost-effectiveness analysis and inform the implementation of these strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We leveraged databases from five large cities in Brazil (Manaus, Recife, Porto Alegre, S\u00e3o Paulo and Rio de Janeiro) to estimate costs of TB services in 2023 US dollars. We estimated mean costs and 95% uncertainty ranges (95% UR) for specific components and combined these components according to national algorithms for TB diagnosis and treatment in adults and children to estimate costs for different services. We leveraged these outputs to estimate the costs of household contact investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We estimated the mean (95% UR) cost of testing children for TB infection with a tuberculin skin test (TST) or interferon-gamma release assay and providing 3\u2009months of once-weekly isoniazid and rifapentine (3HP) was US$48 ($25\u2013$82) and US$67 ($43\u2013$101), respectively. Providing 6\u2009months of treatment for drug-susceptible tuberculosis (DS-TB) to children was US$557 ($163\u2013$1195). In adults, costs were similar to the cost of TST and 3HP costing US$49 ($25\u2013$86) and 6\u2009months of DS-TB treatment being $583 ($175\u2013$1252). For both children and adults, costs of newer, 6-month treatment regimens for rifampin-resistant tuberculosis (RR-TB) were less expensive than 18-month regimens. In children, the cost was US$4807 ($1559\u2013$10 066) for the 6-month regimen and US$9212 ($2756\u2013$19 567) for the 18-month regimen. Corresponding costs in adults were US$3518 ($1169\u2013$7330) and US$7910 ($2533\u2013$16 717). Across 10\u2009000 households with an index TB patient, we estimated use of a TST and 3HP for TB infection screening and treatment and 6-month regimens for DS-TB and RR-TB disease to cost $1 093 531 (95% UR $409 349\u2013$2 217 054).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There are important cost differences in TB services depending on diagnostic and treatment choices. These data are essential inputs for budgeting and cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002661","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:35:27Z","timestamp":1757914527000},"page":"e002661","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Estimated costs of tuberculosis services in Brazil, 2023"],"prefix":"10.1136","volume":"12","author":[{"given":"Elias","family":"Jabbour","sequence":"first","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Pinto","sequence":"additional","affiliation":[{"name":"Fernandes Figueira National Institute of Women's, Child, and Adolescent Health, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo E","family":"Steffen","sequence":"additional","affiliation":[{"name":"Biomedical Centre, State University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Dockhorn","sequence":"additional","affiliation":[{"name":"National Tuberculosis Program, Ministry of Health, Brasilia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele M","family":"Pelissari","sequence":"additional","affiliation":[{"name":"National Tuberculosis Program, Ministry of Health, Brasilia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M","family":"de Souza","sequence":"additional","affiliation":[{"name":"National Tuberculosis Program, Ministry of Health, Brasilia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"de Souza Alves","sequence":"additional","affiliation":[{"name":"National Tuberculosis Program, Ministry of Health, Brasilia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Qu\u00e9bec, Canada"},{"name":"Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-2166","authenticated-orcid":false,"given":"Jonathon R","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Global and Public Health, McGill University, Montreal, Qu\u00e9bec, Canada"},{"name":"Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"2026010701510314000_12.1.e002661.1","unstructured":"Global Tuberculosis Report 2022, Available: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2022"},{"key":"2026010701510314000_12.1.e002661.2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cid\/ciad290","article-title":"Healthcare Utilization After Respiratory Tuberculosis: A Controlled Interrupted Time Series Analysis","volume":"77","author":"Romanowski","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026010701510314000_12.1.e002661.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101979","article-title":"Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis","volume":"59","author":"Taylor","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026010701510314000_12.1.e002661.4","unstructured":"Brasil. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no brasil. Minist\u00e9rio Da Sa\u00fade; 2019."},{"key":"2026010701510314000_12.1.e002661.5","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(22)01433-7","article-title":"Epidemiological approach to ending tuberculosis in high-burden countries","volume":"400","author":"Marks","year":"2022","journal-title":"The Lancet"},{"key":"2026010701510314000_12.1.e002661.6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1590\/s1806-37562015000004524","article-title":"Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System","volume":"41","author":"Pinto","year":"2015","journal-title":"J Bras Pneumol"},{"key":"2026010701510314000_12.1.e002661.7","doi-asserted-by":"crossref","first-page":"100166","DOI":"10.1016\/j.lana.2021.100166","article-title":"Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis","volume":"8","author":"Bastos","year":"2022","journal-title":"The Lancet Regional Health - Americas"},{"key":"2026010701510314000_12.1.e002661.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059546","article-title":"Cost-effectiveness of Quantiferon\u00ae-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil","volume":"8","author":"Steffen","year":"2013","journal-title":"PLoS One"},{"key":"2026010701510314000_12.1.e002661.9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-022-02378-1","article-title":"Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis","volume":"20","author":"Vesga","year":"2022","journal-title":"BMC Med"},{"key":"2026010701510314000_12.1.e002661.10","unstructured":"Estat\u00edstica ibdge. In: Brasil. Censo 2022: panorama. 2022."},{"key":"2026010701510314000_12.1.e002661.11","unstructured":"World Bank . Open Data: World Bank Group, 2022. Available: https:\/\/data.worldbank.org"},{"key":"2026010701510314000_12.1.e002661.12","unstructured":"Brasil. sistema de gerenciamento da tabela de procedimentos. minist\u00e9rio da sa\u00fade. 2023."},{"key":"2026010701510314000_12.1.e002661.13","unstructured":"Brasil . Fundo Nacional de Sa\u00fade. Minist\u00e9rio da Sa\u00fade, 2023."},{"key":"2026010701510314000_12.1.e002661.14","unstructured":"Brasil . Manual de Recomendacoes e Controle Da Tuberculose No Brasil. 2nd edn. Minist\u00e9rio da Sa\u00fade, 2019."},{"key":"2026010701510314000_12.1.e002661.15","unstructured":"Brasil . Departamento de Inform\u00e1tica Do Sistema \u00danico de Sa\u00fade (SIGTAP). Minist\u00e9rio Da Sa\u00fade, 2023."},{"key":"2026010701510314000_12.1.e002661.16","unstructured":"Brasil . Banco central do brasil. 2023."},{"key":"2026010701510314000_12.1.e002661.17","unstructured":"Brasil . Portal da transpar\u00eancia controladoria-geral da uni\u00e3o. 2023."},{"key":"2026010701510314000_12.1.e002661.18","unstructured":"Global Drug Facility . Stop tb parternship. In: Diagnostics, Medical Devices & Other Health Products Catalog. 2023."},{"key":"2026010701510314000_12.1.e002661.19","unstructured":"Brasil . National Tuberculosis Program. Brasilia: Ministry of Health Brazil, 2023."},{"key":"2026010701510314000_12.1.e002661.20","unstructured":"Banco Central do Brasil. Available: https:\/\/www.bcb.gov.br\/en"},{"key":"2026010701510314000_12.1.e002661.21","unstructured":"Minist\u00e9rio da Sa\u00fade; Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil, 2019. Available: https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/svsa\/tuberculose\/manual-de-recomendacoes-e-controle-da-tuberculose-no-brasil-2a-ed.pdf\/view"},{"key":"2026010701510314000_12.1.e002661.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00070812"},{"key":"2026010701510314000_12.1.e002661.23","unstructured":"Global Tuberculosis Report, 2023, 2023. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023"},{"key":"2026010701510314000_12.1.e002661.24","unstructured":"United Nations. Database on Household Size and Composition, 2022. Available: https:\/\/www.un.org\/development\/desa\/pd\/data\/household-size-and-composition"},{"key":"2026010701510314000_12.1.e002661.25","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3201\/eid2809.220092","article-title":"Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010\u20132016","volume":"28","author":"Campbell","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2026010701510314000_12.1.e002661.26","unstructured":"CDC . Estimates for tb treatment costs (in 2022 u.s. dollars): centers for disease control and prevention. 2022. Available: https:\/\/www.cdc.gov\/tb\/publications\/infographic\/appendix.htm"},{"key":"2026010701510314000_12.1.e002661.27","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0176"},{"key":"2026010701510314000_12.1.e002661.28","doi-asserted-by":"crossref","unstructured":"Vesga JF , Mohamed MS , Shandal M , et al . The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling-up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study. Lancet Global Health 2025.:InPress.","DOI":"10.1016\/S2214-109X(25)00321-3"},{"key":"2026010701510314000_12.1.e002661.29","unstructured":"Global tuberculosis report, 2024. 2024. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/data"},{"key":"2026010701510314000_12.1.e002661.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287961","article-title":"The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021","volume":"18","author":"Noia Maciel","year":"2023","journal-title":"PLoS One"},{"key":"2026010701510314000_12.1.e002661.31","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa2314325","article-title":"Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam","volume":"391","author":"Fox","year":"2024","journal-title":"New England Journal of Medicine"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:52:15Z","timestamp":1767779535000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,9,14]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjresp-2024-002661"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002661","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}